Adven Cura-B2 T4:C10

CBD Dominant

THC 4%

CBD 10%

0 patient reviews • Be the first to review

Overview

Adven Cura-B2 T4:C10 is a cbd dominant medical cannabis strain produced by Adven. At 4% THC, this is a lower-potency option available on UK prescription. Patients commonly report using this strain for chronic pain and anxiety.

Effects

Gentle, non-intoxicating relief. Calming without significant psychoactive effects. Suitable for daytime use.

Flavour Profile

Key Terpenes

LinaloolMyrceneCaryophyllene

Commonly Prescribed For

Chronic PainAnxietySeizuresInflammation

Patient Reviews

Medical Disclaimer: This information is provided for educational purposes only and should not be considered medical advice. Always consult with your prescribing specialist before making any changes to your medication. Individual experiences may vary.